You are here: Industry Insights > acquisition

News List

Merck agrees to acquire Immune Design for $300m pharmaceutical-technology
February 26, 2019
Merck has reached an agreement to acquire all outstanding shares of US-based late-stage immunotherapy firm Immune Design in an all cash deal valued at approximately $300m, or $5.85 per share....
Roche to acquire gene therapy specialist Spark Therapeutics for $4.8bn pharmaceutical-technology
February 26, 2019
Roche has signed a definitive merger agreement to acquire all outstanding shares of US-based gene therapy company Spark Therapeutics for $114.50 per share....
Bausch Health Acquires Eton’s M-100 Investigational Eye Drop americanpharmaceuticalreview
February 20, 2019
Bausch Health Companies and Bausch + Lomb, its wholly owned subsidiary and a leading global eye health company, and Eton Pharmaceuticals announced a subsidiary of Bausch Health has acquired the U.S. rights to Eton Pharmaceuticals' EM-100.....
Lilly closes $8bn Loxo Oncology acquisition pharmaceutical-technology
February 19, 2019
Eli Lilly has completed the acquisition of all outstanding shares of Loxo Oncology in a deal valued at approximately $8bn, boosting its oncology portfolio with precision medicines to potentially treat genomically defined cancers.
Bharat Biotech acquires Chiron Behring Vaccines biospectrumasia
February 18, 2019
Bharat Biotech will acquire 100% equity stake in Chiron Behring Vaccines in an all cash transaction.
Johnson & Johnson to Acquire Auris Health americanpharmaceuticalreview
February 15, 2019
Johnson & Johnson announced that Ethicon entered into a definitive agreement to acquire Auris Health for approximately $3.4 billion in cash....
Aurobindo acquires Apotex’s operations in five European countries expressbpd
February 12, 2019
The company had inked a binding agreement on July 14, 2018
Hitachi to acquire apceth Biopharma biospectrumasia
February 02, 2019
This acquisition is expected to close in April 2019
GSK closes $5.1bn Tesaro acquisition pharmaceutical-technology
January 24, 2019
GlaxoSmithKline (GSK) has completed its acquisition of US-based biopharmaceutical company Tesaro for an aggregate cash consideration of $5.1bn....
Takeda mulling sale of emerging market drugs – report pharmaphorum
January 23, 2019
Takeda could be considering selling some emerging-market drugs in a bid to cut debts following its merger with Shire that completed earlier this month, according to a press report.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page